Riskpilot← Back to searchSign inGet full accessWelitech Oy
OYDissolvedY-tunnus 2626972-9Saarenlahdentie 18-B2Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2025
EUR 121K
-18% vs 2024
EBITDA margin
103.0%
+97% vs 2024
Equity ratio
97.0%
Financial strength
Net profit 2025
EUR 100K
+128% vs 2024
| Revenue | EUR 121K | -18% |
| EBITDA | EUR 125K | +97% |
| Net profit | EUR 100K | +128% |
| Total assets | EUR 411K | +25% |
| Equity | EUR 399K | +23% |
| Employees | 0 | — |
Legal name
Welitech Oy
Y-tunnus number
2626972-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
16. kesäkuuta 2014
Share capital
EUR 12 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-01
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Lääkäriasemat, yksityislääkärit ja vastaavat erikoislääkäripalvelut. Yhtiöllä on oikeus kaikkeen lailliseen liiketoimintaan.
Address
Saarenlahdentie 18-B2
Phone
+3580445858633
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 221 | 153 | 146 | 148 | 121 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 169 | 116 | 92 | 63 | 125 |
| Depreciation & amort. | −0 | −14 | −11 | −8 | −0 |
| EBIT | 169 | 102 | 81 | 56 | 125 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | 169 | 102 | 81 | 56 | 125 |
| Tax | 34 | 21 | −0 | 12 | 25 |
| Net profit | 135 | 81 | 65 | 44 | 100 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 238 | 273 | 313 | 329 | 411 |
| Equity | 196 | 262 | 0 | 325 | 399 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 41 | 11 | 8 | 5 | 12 |
| Total debt | 41 | 11 | 0 | 5 | 12 |
EBITDA margin
103.0%
This company
15.8%
Market median
+552% vs market
20212025
Equity ratio
97.0%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
25.0%
This company
18.4%
Market median
+36% vs market
20212025
Net profit margin
82.4%
This company
8.1%
Market median
+917% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-02 – 2025-12-01
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-02 – 2024-12-01
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-02 – 2023-12-01
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PK Deputy Member | Deputy Member | 2019 |
| Former (2) | ||
KL Deputy Member | Deputy Member | 2014 – 2019 |
MA Chief Executive Officer | Chief Executive Officer | 2014 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Welitech Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karoliina Lyydia Tuominen | Deputy Member | 0 companies |
| Päivi Kristiina Karjalainen | Deputy Member | 0 companies |
| Mika Antero Lähteenmäki | Chief Executive Officer | 0 companies |
| Teemu Valtteri Karjalainen | Board of Directors | 0 companies |